Event
Axxam at Discovery & Development Europe 2026
Date: 15-16 June 2026
Location: Berlin, Germany
- Booth: #12
- Sponsored Talk: Innovative Experimental Approaches to TDP-43 Related Pathologies: From Mechanism to Disease Model
Katie Headland
Senior Director - Business Development UK
Katherina Orellana
Head – BD South Europe & Strategic Accounts
Aurelie Dos Santos
Associate - BD & Sales Benelux
Alessandro Cinti
Scientific Research Expert
Iolanda Micco
Scientific Officer - Integrated Discovery
Event Overview
Axxam will attend Discovery & Development Europe 2026 in Berlin on 15–16 June 2026. The company will exhibit at booth #12 and Alessandro Cinti will deliver a sponsored talk titled Innovative Experimental Approaches to TDP-43 Related Pathologies: From Mechanism to Disease Model within the Neuroscience Drug Development track.
Meet Axxam at booth #12
Axxam will attend Discovery & Development Europe 2026, taking place 15–16 June 2026 in Berlin, Germany, an event bringing together drug discovery, neuroscience, formulation and delivery experts across two days of scientific exchange.
Meet our team at booth #12 to discuss how Axxam supports early drug discovery with integrated assay development, high-throughput screening, translational models and advanced technologies for complex biology.
Sponsored Talk
Innovative Experimental Approaches to TDP-43 Related Pathologies: From Mechanism to Disease Model
Speaker: Alessandro Cinti, Axxam
Track: Neuroscience Drug Development – Translating Targets Into Therapies
Duration: 30 minutes
During the talk, Alessandro will present innovative experimental approaches to investigate TDP-43 related pathologies, connecting mechanistic insights with disease-relevant models to support neuroscience drug discovery.
Why connect with Axxam?
Axxam provides flexible discovery support, from stand-alone services to integrated programs, helping partners generate robust, decision-ready data in complex disease areas.
Our capabilities include:
- Advanced translational models
iPSC-derived models, high-content imaging, 3D systems and disease-relevant assays. - Neuroscience expertise
Assay development and profiling strategies for neurodegeneration and complex CNS biology. - Integrated discovery workflows
Connected technologies from assay development to screening, hit validation and deeper compound characterization. - Advanced electrophysiology and organellar platforms
Including automated patch clamp, MEA and LysoPatch™ technologies.
Planning to attend Discovery & Development Europe 2026?
Visit Axxam at booth #12 or contact us to schedule a meeting with our team.